首页/数据集/HNRNPA2B1 as a potential therapeutic target for thymic epithelial tumor recurrence

HNRNPA2B1 as a potential therapeutic target for thymic epithelial tumor recurrence

Name: HNRNPA2B1 as a potential therapeutic target for thymic epithelial tumor recurrence
Creator: Shanghai Jiao Tong University
Published: 2023-01-31T11:18:52+08:00

integrated proteome resources2026-02-07 收录

肿瘤靶向治疗

胸腺上皮肿瘤复发

数据链接：

https://www.iprox.cn/page/project.html?id=IPX0005814000 数据链接链接失效反馈

官方服务：

资源简介：

HNRNPA2B1 as a potential therapeutic target for thymic epithelial tumor recurrence

应用场景：

提供机构：

Shanghai Jiao Tong University

创建时间：

2023-01-31

蛋白质降解

药物设计

Structure-guided development of chemically tailored peptide binders of RNF43/ZNRF3 to enable versatile design of membrane protein-targeting PROTACs

integrated proteome resources110

肿瘤靶分子临床研究信息数据集

肿瘤靶向治疗

临床研究

聚焦肿瘤靶分子临床研究全流程，整合靶点发现、临床试验设计、疗效数据、安全性评估等核心信息。数据经标准化清洗与专业校验，关联靶点分子结构、作用机制及临床结果，支持科研机构靶点验证、药企药物研发、临床机构方案优化，为靶分子临床转化提供高质量、可溯源的数据支撑。

江苏数据交易所80

Neurotrophic tropomyosin receptor kinase (NTRK) fusion positive tumors: a historical cohort analysis

NTRK融合肿瘤

肿瘤靶向治疗

NTRK gene fusions have been identified in various tumors; some requiring aggressive therapy and sometimes new TRK inhibitors (TRKi). We aimed to describe a national, unselected, retrospective, multice

Figshare2023-08-01 更新10

SAM Competitive PRMT5 Inhibitor PF-06939999 Demonstrates Antitumor Activity in Splicing Dysregulated NSCLC with Decreased Liability of Drug Resistance

肿瘤靶向治疗

药物耐药机制

Protein arginine methyltransferase 5 (PRMT5) over-expression in hematological and solid tumors methylates arginine residues on cellular proteins involved in important cancer functions including cell c

NIAID Data Ecosystem90

Codes and dataset for CNN recognition

卷积神经网络识别

设备视觉应用

codes and dataset for research published in Device

Zenodo2025-04-02 更新20